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Understanding the kinds of evidence available and using the best evidence to answer a question is 
critical to evidenced-based decision-making, and it requires synthesis of evidence from a variety of 
sources. Categorization of human system risks in spaceflight, in particular, focuses on how well the 
integration and interpretation of all available evidence informs the risk statement that describes the 
relationship between spaceflight hazards and an outcome of interest. A mature understanding and 
categorization of these risks requires: 1) sufficient characterization of risk, 2) sufficient knowledge to 
determine an acceptable level of risk (i.e., a standard), 3) development of mitigations to meet the 
acceptable level of risk, and 4) identification of factors affecting generalizability of the evidence to 
different design reference missions. In the medical research community, evidence is often ranked by 
increasing confidence in findings gleaned from observational and experimental research (e.g., “levels of 
evidence”). However, an approach based solely on aspects of experimental design is problematic in 
assessing human system risks for spaceflight. For spaceflight, the unique challenges and opportunities 
include: 
1. The independent variables in most evidence are the hazards of spaceflight, such as space radiation 
or low gravity, which cannot be entirely duplicated in terrestrial (Earth-based) analogs. 
2. Evidence is drawn from multiple sources including medical and mission operations, Lifetime 
Surveillance of Astronaut Health (LSAH), spaceflight research (LSDA), and relevant 
environmental & terrestrial databases. 
3. Risk metrics based primarily on LSAH data are typically derived from available prevalence or 
incidence data, which may limit rigorous interpretation. 
4. The timeframe for obtaining adequate spaceflight sample size (n) is very long, given the small 
population. 
5. Randomized controlled trials are unattainable in spaceflight.  
6. Collection of personal and environmental data on the astronaut population may create 
opportunities for advanced analytics and human-environment modeling that goes beyond that 
achieved in isolated experimental designs. 
7. Translation of relevant research to operations is a complex, transdisciplinary enterprise in which 
the approach must apply across the physical, biological, behavioral, and social sciences. 
The approach to synthesizing evidence must address both source and fidelity of data, and reflect 
the most general attributes of quality of evidence in science and engineering: reliability and validity. The 
authors are developing a two-factor approach which includes the various kinds of evidence required to 
understand risks and for the integrated interpretation of all evidence that is essential to develop standards 
and countermeasures. A unified framework for aggregating and assessing different kinds of evidence 
provides a consistent, traceable, evidence-based decision-making process to translate research to 
operations in an environment where engineers, scientists, physicians, and managers all engage in 
analyzing the trade space of vehicle design, standards, requirements and solutions for spaceflight.  
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